| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |